Logmind
Non Equity Assistance in 2024
Logmind designs a cloud-based, AI-accelerated log data analytics platform that provides visibility into unstructured log data and automated insights. The platform enables IT operations and DevOps teams to automatically detect application issues, investigate and discover root causes, visualize and monitor trends, and receive alerts and recommendations. It analyzes logs from complex IT infrastructures to transform scattered data into operational intelligence, helping organizations run applications more reliably and avoid costly incidents. Established in 2018 and based in Lausanne, Switzerland, Logmind focuses on turning unstructured log streams into actionable, real-time insights.
AICA SA
Non Equity Assistance in 2024
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
Genknowme
Non Equity Assistance in 2024
Genknowme S.A. is a life science company based in Lausanne, Switzerland, founded in 2019. It specializes in personalized epigenetic testing that assesses the impact of lifestyle and environmental factors on biological age. By utilizing DNA methylation biomarkers, Genknowme quantifies how various elements such as diet, physical activity, tobacco use, and alcohol consumption affect an individual's health. The company's innovative platform provides health-conscious individuals with actionable insights, empowering them to make informed decisions about their lifestyle and seek proactive care based on their genetic predispositions.
Volumina Medical
Non Equity Assistance in 2024
Volumina Medical SA is a Swiss company specializing in the development, manufacturing, and commercialization of advanced tissue reconstruction technologies tailored for the reconstructive and plastic surgery markets. The company focuses on tissue engineering, creating injectable 3D scaffolds that facilitate the reconstruction of lost soft tissue volumes due to tumor ablation, disease, trauma, or aesthetic needs. These innovative scaffolds can be administered through thin cannulas, which helps reduce both intervention and recovery times for patients, addressing the challenges associated with the natural repair of three-dimensional soft tissues.
Aspivix
Non Equity Assistance in 2024
Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.
RigiTech
Non Equity Assistance in 2024
RigiTech specializes in developing advanced drone technologies for efficient, environmentally friendly deliveries. Their innovative solutions aim to enhance accessibility to goods for communities, governments, and businesses.
TreaTech
Non Equity Assistance in 2024
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.
Flybotix
Non Equity Assistance in 2024
Flybotix specializes in manufacturing drones designed specifically for indoor inspection tasks within narrow spaces. Their drones serve the oil and gas, energy, and mining industries by providing safe and efficient inspections of infrastructure in confined areas.
Dotphoton
Non Equity Assistance in 2024
Dotphoton AG is a Swiss company established in 2017, specializing in raw image compression software solutions tailored for sectors such as earth observation, life sciences, biomedical research, and aerial photography. The company offers a range of products, including Dotphoton CV, which caters to raw data users, and Dotphoton Core, designed for camera and optical system manufacturers. Additionally, Dotphoton Raw is a desktop application that effectively reduces raw files from cameras while preserving edits and enabling automatic file relinking. Dotphoton's innovative technology, rooted in quantum physics research, allows for significant storage savings—up to ten times less space—while ensuring high-quality image retention. The company focuses on providing professional customers with advanced image compression solutions, including software, intellectual property licensing, and comprehensive support services.
Limula
Non Equity Assistance in 2024
Limula develops an automated cell therapy manufacturing platform that combines bioreactor and centrifuge capabilities into a single device, supported by hardware, software, and consumables. The platform enables scalable, decentralized production of cell therapies by bringing manufacturing closer to patients and supporting multiple cell types. It automates complex processing steps within a closed, modular system, allowing biotech and pharmaceutical companies to move from open, manual methods to automated operations, improving efficiency, safety, and accessibility of personalized treatments.
Roumai
Non Equity Assistance in 2024
Roumai Medical is a pioneering company specializing in the development of advanced, reliable implantable medical devices. Their portfolio includes tissue-engineered blood vessels, intelligent stent systems, and portable electroporators, designed to improve clinical outcomes and extend life expectancy for patients with cardiovascular, cerebrovascular, and diabetic conditions.
MeduSoil
Non Equity Assistance in 2024
Founded in 2018, MeduSoil specializes in producing and commercializing a soil stabilization agent that induces mineral calcite formation underground. Its patented technology addresses construction challenges like soil erosion, landslide mitigation, and soil consolidation, transforming typical soil into a strong, rock-like foundation.
Covantis
Non Equity Assistance in 2024
Covantis is a technology company that develops a blockchain-based digital platform for post-trade execution in commodities trading and shipping, with a focus on international agriculture bulk commodities. The platform reduces operating risks and enhances market efficiency by digitalizing contract management, vessel finalization, and related processes, replacing manual and redundant workflows and improving information flows to help clients track changes in the commodity market.
Smeetz
Non Equity Assistance in 2024
Founded in 2016, Smeetz is a Swiss-based company offering an AI-powered commerce intelligence platform tailored for the leisure and entertainment industry. Its comprehensive suite of solutions includes ticketing, POS, CRM, data analytics, and dynamic pricing, empowering venues to optimize efficiency, increase revenue, and enhance guest experiences.
DomoHealth
Non Equity Assistance in 2024
DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.
Artifact
Non Equity Assistance in 2024
Artifact engages in accelerating impact with data science.
Resilient is a Lausanne-based AI startup dedicated to improving employee wellbeing and preventing burnout. Leveraging AI agents and a multi-agent framework, Resilient provides a personalized, data-driven wellbeing coach that integrates coaching and therapy principles for continuous support. The platform also offers organizations an anonymized HR dashboard to uncover and address systemic issues, fostering a healthier and more resilient workplace culture.
Company registration: https://prestations.vd.ch/pub/101266/